Daclizumab + Ocrelizumab And Hyaluronidase Interaction
Unknowninteraction on record
Description
When switching from drugs with prolonged immune effects, such as daclizumab, fingolimod, natalizumab, teriflunomide, or mitoxantrone, consider the duration and mode of action of these drugs because of additive immunosuppressive effects when initiating OCREVUS ZUNOVO [see Warnings and Precautions (5.2) ].
Source: FDA drug label - ocrelizumab and hyaluronidase